###begin article-title 0
Gene expression profiling in sinonasal adenocarcinoma
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Sinonasal adenocarcinomas are uncommon tumors which develop in the ethmoid sinus after exposure to wood dust. Although the etiology of these tumors is well defined, very little is known about their molecular basis and no diagnostic tool exists for their early detection in high-risk workers.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
To identify genes involved in this disease, we performed gene expression profiling using cancer-dedicated microarrays, on nine matched samples of sinonasal adenocarcinomas and non-tumor sinusal tissue. Microarray results were validated by quantitative RT-PCR and immunohistochemistry on two additional sets of tumors.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 69 101 69 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4, ACS5, CLU, SRI and CCT5 </italic>
###xml 148 165 148 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4, ACS5, SRI</italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5 </italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
Among the genes with significant differential expression we selected LGALS4, ACS5, CLU, SRI and CCT5 for further exploration. The overexpression of LGALS4, ACS5, SRI, CCT5 and the downregulation of CLU were confirmed by quantitative RT-PCR. Immunohistochemistry was performed for LGALS4 (Galectin 4), ACS5 (Acyl-CoA synthetase) and CLU (Clusterin) proteins: LGALS4 was highly up-regulated, particularly in the most differentiated tumors, while CLU was lost in all tumors. The expression of ACS5, was more heterogeneous and no correlation was observed with the tumor type.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Within our microarray study in sinonasal adenocarcinoma we identified two proteins, LGALS4 and CLU, that were significantly differentially expressed in tumors compared to normal tissue. A further evaluation on a new set of tissues, including precancerous stages and low grade tumors, is necessary to evaluate the possibility of using them as diagnostic markers.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 601 602 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 810 811 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1859 1861 1859 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 2277 2283 2277 2283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 2284 2286 2284 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 2421 2446 2421 2446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB1, CCND1, ERBB2, TP53</italic>
###xml 2448 2461 2448 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras, COX-2 </italic>
###xml 2464 2467 2464 2467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 2578 2580 2578 2580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 2581 2583 2581 2583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2584 2586 2584 2586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 2726 2728 2726 2728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2729 2731 2729 2731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2897 2899 2897 2899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 134 137 <span type="species:ncbi:9606">men</span>
###xml 1026 1033 <span type="species:ncbi:4097">tobacco</span>
Sinonasal adenocarcinoma is a rare cancer which usually develops in the ethmoid sinuses. It mainly develops amongst 30 to 85 year old men, with a high frequency around 60. The incidence of this type of cancer was estimated by the IARC (International Agency for Research on Cancer) at 0.7/100 000 in China to 1.4/100 000 in USA and 1.5/100 000 in France, and it has been reported to account for 3% of head and neck tumors [1,2]. This cancer is recognized as an occupational cancer. In fact, it is well confirmed today that sinonasal adenocarcinoma is highly correlated with duration and level (3.5 mg/m3) of wood dust exposure [3,4]. As such, woodworkers have very high risks of nasal cancer (Standard Mortality Ratio: 310, 95% CI, 160-560) [5,6]. Other suspected risk factors include exposure to leather dust [7,8], metals such as chromium or nickel [9,10], and formaldehyde, although the epidemiological data regarding this chemical are partly conflicting [4,11]. In contrast to most other head and neck cancers, alcohol and tobacco do not seem to be risk factors [12]. Although the etiology of sinonasal adenocarcinoma is well-defined, its wood-related pathogenesis is not clearly understood [13]. From a morphological and histopathological point of view, these tumors are mainly intestinal-type adenocarcinomas [14,15] and demonstrate characteristic changes, such as gland formation, seen in adenocarcinomas at other anatomic sites. The most common clinical symptoms (nosebleeding, rhinitis and nasal obstruction) are not specific and this explains the delay in the diagnosis and the frequency of advanced stages. The conventional treatment includes local surgery [16] associated with radiotherapy. The survival rate at 5 years is only about 50% and it is important to point out that secondary effects are considerable due to the location of these tumors [17]. Therefore, early detection and alternative treatments are necessary. This requires, however, better knowledge of the molecular mechanisms involved in the development of these tumors. Although many reports on epidemiological studies and risk factors of sinonasal adenocarcinomas have been published, only a small number of reports have been made so far on their molecular biology. As reviewed recently by Llorente et al [13], several groups have proceeded with molecular studies of sinonasal adenocarcinomas. However these focused on specific genes, such as ERBB1, CCND1, ERBB2, TP53, K-ras, COX-2 or APC, involved either in other head and neck tumors or in colorectal cancer because of morphological similarities [13,18,19]. Two groups reported comparative genomic hybridization in ethmoid sinus adenocarcinomas and revealed hot spots of chromosomal imbalances [20-22]. Global genetic modifications (micronuclei and chromosomal aberrations) were also found in buccal epithelial cells and blood lymphocytes of wood furniture workers [23]. The conclusion of all these investigations is that ethmoid sinus adenocarcinomas have their own molecular development pathway.
###end p 10
###begin p 11
###xml 577 584 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 588 591 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
Thus, to identify genes involved in this pathway, we pioneered a gene expression profiling study of 9 sinonasal adenocarcinomas versus their matched normal tissue. We found 186 genes with significant differential expression. The further evaluation of several selected genes by reverse-transcription quantitative real-time-PCR (RT-qPCR) and immunohistochemistry (IHC), on two additional validation samples, confirmed the microarray data. We have hereby opened up a new field of investigation into biomarkers of this tumor type and have identified two promising candidate genes: LGALS4 and CLU.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
Our study included 26 patients. A first set of 19 male patients undergoing surgery for ethmoid sinus adenocarcinomas were initially included between 2004 and 2006. Following this, a second set of 7 patients whose samples were collected from 2006 to 2007 was used to complete the immunohistochemistry study.
###end p 14
###begin p 15
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
###xml 516 523 <span type="species:ncbi:4097">tobacco</span>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
###xml 656 663 <span type="species:ncbi:9606">Patient</span>
###xml 738 746 <span type="species:ncbi:9606">patients</span>
This project was approved by the Clinical Board of the Centre Hospitalo-Universitaire of Nantes and all included patients provided written informed consent in accordance with French regulations and the Declaration of Helsinki. All patients answered a codified questionnaire regarding occupational exposures, addictive consumption and family history. Twenty three patients out of 26 were exposed to wood dust and most of them had other occupational exposures (such as solvents and pesticides) sometimes combined with tobacco and/or alcohol. Two patients were exposed to leather dust (P7, P19), whereas only one (P10) had no occupational exposure (Table 1). Patient ages ranged from 50 to 80 years with a mean age of 69 years. To date, six patients have died as a direct result of their disease (Table 1).
###end p 15
###begin p 16
Summary of clinical data and use of tumor samples
###end p 16
###begin p 17
a: dust exposure: W = wood, L = leather
###end p 17
###begin p 18
b: pesticides (xylophene), solvents (acetone, formaldehyde)
###end p 18
###begin p 19
c: R = recurrent tumor
###end p 19
###begin p 20
d: treatment: S = surgery, R = radiotherapy post-surgery
###end p 20
###begin p 21
e: DOD = death from the disease, D = death from other causes, A = alive
###end p 21
###begin title 22
Tissue specimens
###end title 22
###begin p 23
###xml 525 527 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 821 823 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 824 826 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 53 60 <span type="species:ncbi:9606">patient</span>
Two pieces of tissue samples were obtained from each patient undergoing surgery for ethmoidal adenocarcinoma: one from the tumor and one non-tumor sample obtained from the opposite sinus at 3 to 4 cm distance (herein referred to as "normal" tissue). All samples were immediately frozen and stored at -80degreesC. Remaining surgical resections of tumors and normal tissue were fixed in 10% formalin and embedded in paraffin before histological examination and diagnosis according to World Health Organization recommendations [24]. Two main types of sinonasal adenocarcinoma are recognized in the ethmoid sinus based on the histological similarity to adenocarcinoma of the intestine: Intestinal Type Adenocarcinoma (ITAC) and non-Intestinal Type Adenocarcinoma (non-ITAC). ITAC can be further divided into five categories [15,25]: the "papillary-type" (well-differentiated adenocarcinoma), the "colonic-type" (moderately-differentiated adenocarcinoma), the "solid-type" (poorly-differentiated adenocarcinoma), the "mucinous--type" and the "mixed--type" composed of a mixture of the previously defined patterns. Non-ITAC are divided into low-grade and high-grade subtypes.
###end p 23
###begin title 24
RNA extraction
###end title 24
###begin p 25
###xml 839 840 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
On each matched normal and pathological tissue specimen from patients P1 to P19, two RNA extractions were performed from about 40 frozen sections (10 mum thick) using a Total RNA and Protein Isolation kit (Macherey-Nagel, Duren, Germany) according to the manufacturer's instructions. For each sample, the first and last sections were stained with hemalun/phloxin to confirm the histology and to evaluate the percentage of tumor tissue. 10 samples had to be eliminated for microarray analysis because of necrosis or a too low percentage of non-necrotic tumor tissue (less than 50%). Six out of these ten patients were included in the validation process by RT-qPCR as this technique is more sensitive than microarrays for identifying tumor cells within a sample. The other samples were completely excluded from the molecular analysis (Table 1).
###end p 25
###begin p 26
###xml 311 313 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
The quantity and quality of each RNA were respectively evaluated with the NanoDrop(R) ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE) and the Agilent 2100 Bioanalyser (Agilent, Santa Clara, CA). The RNAs extracted were of good quality and the RNA integrity number (RIN) was >7.5 in all cases [26].
###end p 26
###begin title 27
RNA amplification and microarray hybridization
###end title 27
###begin p 28
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Cancer-dedicated microarrays were prepared in-house (ADN-OGP- Microarray Platform Nantes, France) with methods previously described in detail [27,28] using 22,175 probe sets (50-mer oligonucleotides - MWG Biotech, Roissy, France) interrogating 6,864 genes involved in different types of tumors. These microarrays therefore included triplicate probes for each gene, housekeeping genes and controls.
###end p 28
###begin p 29
###xml 116 119 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 643 645 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 646 648 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 907 909 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1110 1113 1101 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
For microarray analysis one round of amplification was conducted on 500 ng total RNA using an Amino Allyl MessageAmp(R)II aRNA Amplification kit (Ambion, Austin, TX) according to the manufacturer's instructions, and the quantity and quality of each amplified RNA (aRNA) were again evaluated. Microarrays were carried out in duplicate for both RNA extractions of each tissue except for two patients as not enough RNA was available. The targets were prepared by labeling with Cy3-dUTP aRNA from the tumor and normal tissues. In order to reduce individual variations, the reference was prepared by mixing an equal quantity of all normal tissues [29,30] and aliquots were then labeled with Cy5-dUTP (Amersham Biosciences, Piscataway, NJ). Each Cy3-dUTP sample was mixed with an equal amount of Cy5-dUTP reference sample and the mixture was applied to microarray slides for hybridization at 40degreesC for 16 h [27]. The slides were then washed twice at room temperature for 2 min with 2x SSC and 0.1% SDS, for 2 min with 1x SSC, and twice for 2 min with 0.2x SSC and scanned at 10 mum/pixel resolution by ScanArray(R)ExpressHT (PerkinElmer Life Sciences, Boston, MA).
###end p 29
###begin title 30
Microarray data analysis
###end title 30
###begin p 31
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
Scanned signals were quantified from all microarrays by GenePix Pro software version 5.1 (Axon Instruments, Union City, CA) and consolidated expression values were performed by MADSCAN software in five steps [30,31]. The information was extracted from the features close to the background or saturated and normalization was performed by the rank invariant and lowest fitness method with spatial normalization. Outlier values were eliminated with the spots in triplicate and biological replicates. To identify genes differentially expressed in tumor samples, a two-class comparison analysis by Significance Analysis of MicroArray (SAM) [32] was performed on data filtered by differences between normal and pathological tissue medians as previously described [30] and genes with differential expression were visualized using Cluster [33] and Tree view [31]. An unsupervised clustering was also performed with a hierarchical clustering algorithm [33] using the Pearson coefficient and Student test. The clusters of genes with the same regulation were functionally annotated by GoMiner [34].
###end p 31
###begin p 32
The data have been incorporated into the NCBI Gene Expression Omnibus (GEO)  and are accessible through GEO Series GPL 8957 and GSE 17433.
###end p 32
###begin title 33
cDNA synthesis and real-time PCR (RT-qPCR)
###end title 33
###begin p 34
###xml 469 470 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 717 718 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1052 1054 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1107 1113 1086 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO </italic>
###xml 1145 1149 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBC </italic>
###xml 1167 1174 1146 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2M </italic>
To confirm the microarray data we performed quantitative RT-PCR on selected genes using the MX4000 system and the Brilliant SYBR Green QPCR Core Reagent Kit (Stratagene, La Jolla, CA). Initially, cDNA was prepared in 20 mul using 1 mug of DNase-treated total RNA and the SuperScript III Reverse Transcriptase System (Invitrogen, Carlsbad, CA). Following a 5 fold dilution, 2 mul of each sample were used for RT-qPCR with the different pairs of primers (Additional file 1: "Primers sequences"). The following PCR cycle parameters were used: hot-start DNA polymerase activation 95degreesC for 10 min, 40 cycles with denaturation at 95degreesC for 30 sec, specific annealing temperature as indicated in "Additional file 1: Primer sequences" for 30 sec and extension at 72degreesC for 30 sec. Each reaction was run in duplicate. The threshold cycles, obtained from the MX4000 software, were averaged (SD<0.5). Relative expression of the target gene in the tumor versus matched normal tissue was calculated using the following equation described by Pfaffl [35], using the average Ct of three housekeeping genes: RPLPO (Ribosomal Protein, Large, PO), UBC (Ubiquitin C) and beta2M (beta-2 microglobulin):
###end p 34
###begin p 35
###xml 24 31 <span type="species:ncbi:9606">patient</span>
Relative expression per patient and per gene:
###end p 35
###begin p 36
GOI = gene of interest
###end p 36
###begin p 37
HK = housekeeping gene (average of Ct of the three housekeeping genes).
###end p 37
###begin p 38
Eff = efficiency of the RT-qPCR obtained from the standard curve
###end p 38
###begin p 39
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
Statistical significance was obtained using a pair-wise fixed reallocation randomization test using the REST software [36]. To insure specificity of the RT-qPCR, an agarose gel electrophoresis was initially performed to verify whether a single PCR product was generated and then a melting curve was performed at the end of each RT-qPCR. Linearity and efficiency of the RT-qPCR were checked for each gene with a standard curve of 4 logs prepared with Universal RNA (Stratagene-AGILENT, CA). Efficiency was >90% in all cases.
###end p 39
###begin title 40
Immunohistochemical analysis
###end title 40
###begin p 41
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
Protein expression of selected genes was assessed in deparaffinized 5-mum sections of normal and pathological formalin-fixed tissue from 26 patients with sinonasal adenocarcinomas included in the study. The following antibodies were used: monoclonal antibody against human Clusterin (clone CLI-9, Alexis Corporation Lausen, Switzerland, 1:500 dilution), monoclonal antibody against human Acyl CoA synthetase 5 (ACS5) (Abnova, Jhongli City, Taiwan 1:200 dilution at 4degreesC overnight), polyclonal antibody against Galectin-4 (T-20) (Santa Cruz, Heidelberg, Germany, 1:50 dilution). All specimens were submitted to heat-induced antigen retrieval and processed using the EnVision Detection Kit (DAKOCYTOMATION, Trappes, France), except for LGALS4 that was processed using ABC VECTASTAIN Elite ABC Kit (Burlingame, CA), with 3,3'-diaminobenzidine as chromatogen and a hematoxylin counterstain. In each experiment, negative controls were performed by omitting the primary antibody.
###end p 41
###begin title 42
Results
###end title 42
###begin title 43
Microarray analysis
###end title 43
###begin p 44
###xml 105 110 <span type="species:ncbi:9606">human</span>
Gene expression profiles of 9 ethmoid adenocarcinomas were examined using microarrays consisting of 6864 human genes involved in many types of cancers.
###end p 44
###begin p 45
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACS5 </italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRI </italic>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
With the two-class comparison SAM, 186 genes were found to be significantly differentially expressed between ethmoid adenocarcinomas and normal sinonasal tissue. Among these 186 genes, 150 were up-regulated and 36 were down-regulated (Figure 1A and "Additional File 2: Genes with significant differential expression"). The top 59 genes (1< fold change < -1) are described in Table 2. The genes with the highest fold expression variation were selected for validation by RT-qPCR: LGALS4 (fold change: 3.6), ACS5 (fold change: 2.1), and CLU (fold change: -3.6). By unsupervised clustering (i.e. without any initial classification of the samples) 7 tumors out of 9 were separated from normal samples (Figure 1B). However, 5 clusters of genes with differential expression between tumor and normal samples were revealed. Using GoMiner [34] the genes involved in metabolism and biosynthesis functions were found to be overexpressed, whereas those involved in transcription, angiogenesis, cellular signaling and mitochondrial functions were down-regulated. Based on this non-supervised analysis 2 more genes with high differential expression were selected for RT-qPCR analysis: SRI and CCT5. Involved in drug resistance, these genes also featured in the list of overexpressed genes obtained from the two-class comparison analysis, with a fold change of 1.5 and 0.9 respectively.
###end p 45
###begin p 46
Top 59 genes differentially expressed in sinonasal adenocarcinomas after two-class comparison analysis
###end p 46
###begin p 47
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Heat map of the two-class comparison (A) and unsupervised (B) analysis</bold>
Heat map of the two-class comparison (A) and unsupervised (B) analysis. Expression levels are color coded with red, green, black and gray, corresponding to an increase, decrease or no change in gene expression, or missing data, respectively.
###end p 47
###begin title 48
Relative expression level of selected genes
###end title 48
###begin p 49
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
To validate the differential gene expression obtained by microarray analysis, quantitative PCR analysis of the selected genes was performed in matched sets of tumors and normal tissues. The patients used for microarray analysis and 6 additional patients were included. As RNA from normal tissue was no longer available, we used the Ct average (SD<1Ct) of all normal tissues for P8 and P19 patients to calculate the relative expression level of each gene [35].
###end p 49
###begin p 50
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACS5 </italic>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACS5</italic>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A-B</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 696 708 696 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRI and CCT5</italic>
###xml 854 855 854 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
A significant differential expression in tumor tissue versus normal tissue was confirmed for all selected genes. The genes with the highest overexpression were LGALS4 with a mean ratio of 1309 (0.17-5993, p = 0.001), then ACS5 with a mean ratio of 9.48 (0.14-23.55, p = 0.001). P10 and P11 patients overexpressed neither LGALS4 nor ACS5. (Figure 2A-B). CLU was highly down-regulated in most of the tumors (mean ratio:0.044, 0.005-0.26, p = 0.001) (Figure 2C). Many isoforms of CLU have been described in the literature [37], and we quantified by RT-qPCR the main ones, i.e. the nuclear form (n-clu) and the cytosolic form (s-clu). Both were found to be down-regulated (data not shown). Regarding SRI and CCT5, their significant up regulation was confirmed (p = 0.0016 and p = 0.006 respectively) although the fold change was much lower ("Additional file 3: Relative expression of SRI and CCT5").
###end p 50
###begin p 51
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACS5</italic>
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relative expression levels of <italic>LGALS4</italic>, <italic>ACS5</italic>, <italic>CLU</italic>, in tumors versus matched normal sinusal tissue as determined by RT-qPCR</bold>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO</italic>
###xml 289 308 289 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2 microglobulin</italic>
###xml 314 325 311 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin C</italic>
Relative expression levels of LGALS4, ACS5, CLU, in tumors versus matched normal sinusal tissue as determined by RT-qPCR. Fold change was calculated according to the equation described in the Materials and Methods with normalization against the average of three housekeeping genes, RPLPO, beta2 microglobulin, and ubiquitin C. *tumor tissue versus average of all normal sinusal tissues (cf. RT-qPCR Results for details).
###end p 51
###begin title 52
Immunohistochemical analysis of LGALS4, ACS5 and CLU
###end title 52
###begin p 53
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 682 688 682 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A-B-C</xref>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
To confirm the variation in expression of the selected genes at the protein level, we performed immunohistochemical analysis of matched normal sinonasal and tumor tissues from the 15 patients used for the molecular analysis as well as from an independent set of 11 other patients, using specific antibodies for LGALS4, ACS5 and CLU (Table 3). In the normal sinusal mucosa, these three markers were expressed by serous cells of the seromucinous glands present in the lamina propria. A weak and focal cytoplasmic staining of a small number of seromucinous glands was observed with the antibodies against LGALS4 and CLU while the staining was more intense and diffuse for ACS5 (Figure 3A-B-C). Among the 26 tumors analyzed, only 2 were high-grade non-ITAC and the others were ITAC: 5 "papillary-type" (well-differentiated adenocarcinoma), 2 "colonic-type" (moderately-differentiated adenocarcinoma), 9 "mucinous-type" adenocarcinoma and 8 mixed-type adenocarcinoma (Table 3).
###end p 53
###begin p 54
LGALS4, ACS5 and CLU expression in 26 sinonasal adenocarcinomas (IHC analysis).
###end p 54
###begin p 55
###xml 2 10 <span type="species:ncbi:9606">Patients</span>
* Patients exposed to leather dust
###end p 55
###begin p 56
** No occupational exposure
###end p 56
###begin p 57
a- Intensity of immunostaining in tumoral cells:
###end p 57
###begin p 58
+++: positivity of 75 to 100% of cells with an strong staining.
###end p 58
###begin p 59
++: positivity of 25 to 75% of cells with heterogenous weak to strong staining.
###end p 59
###begin p 60
+: focal and weak positivity of 1 to 25% of cells.
###end p 60
###begin p 61
-: no staining.
###end p 61
###begin p 62
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Representative cases of LGALS4, CLU and ACS5 expression in matched normal mucosa (&#215;100), and tumor tissue (&#215;25)</bold>
###xml 572 579 <span type="species:ncbi:9606">patient</span>
###xml 739 746 <span type="species:ncbi:9606">Patient</span>
Representative cases of LGALS4, CLU and ACS5 expression in matched normal mucosa (x100), and tumor tissue (x25). A-B-C: Normal sinusal mucosa immunostaining. (A-C): Weak and focal cytoplasmic staining of serous cells in a few seromucinous glands with LGALS4 and CLU. (A):Weak staining of respiratory epithelium with LGALS4. (B): Strong and diffuse immunostaining of serous cells with ACS5. D-E-F: Tumor immunostaining. (D): Poorly-differentiated "solid-type" component showing no immunoreactivity for LGALS4 while the "colonic-type" component is positive in a mixed ITAC (patient 5). (E): Example of ACS5 expression in a "colonic-type" ITAC. (F): No immunoreactivity for CLU in tumor samples (x100) except in one non-ITAC (Insert * (x25), Patient 11).
###end p 62
###begin p 63
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
With the LGALS4 antibody the ITAC tumor cells displayed a strong cytoplasmic and membranous staining with an additional nuclear staining in the well-differentiated adenocarcinomas. Interestingly, in a mixed ITAC sample (P5) the poorly differentiated "solid-type" component showed no immunoreactivity for LGALS4 while the "colonic-type" component was positive (Table 3 and Figure 3D). Non-ITAC samples displayed no LGALS4 expression.
###end p 63
###begin p 64
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3E</xref>
For ACS5, fifty percent of the tumor samples were negative while the remaining 50% showed a weak to strong cytoplasmic staining without any correlation with the histological type or with the differentiation of the tumor (Table 3 and Figure 3E).
###end p 64
###begin p 65
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3F</xref>
###xml 108 115 <span type="species:ncbi:9606">Patient</span>
In contrast to normal mucosa, CLU was found to be absent in tumors except in one high-grade non-ITAC tumor (Patient P11) where there was a diffuse cytoplasmic staining (Table 3 and Figure 3F).
###end p 65
###begin title 66
Discussion
###end title 66
###begin p 67
Ethmoid carcinomas are uncommon tumors recognized as an occupational disease amongst woodworkers. Current treatment with surgery and radiotherapy is unsatisfactory given the 50% survival at 5 years and the serious side effects. To better understand the molecular events involved in this tumor and to identify potentially novel markers we pioneered a gene expression profiling study of 9 sinonasal adenocarcinomas.
###end p 67
###begin p 68
###xml 135 166 135 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4, ACS5, CLU, SRI and CCT5</italic>
###xml 289 313 289 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4, ACS5, SRI, CCT5 </italic>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 470 483 470 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4, ACS5 </italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
This study, using dedicated-microarrays containing 6864 genes previously known to be involved in cancer, allowed us to select 5 genes (LGALS4, ACS5, CLU, SRI and CCT5) with significant differential expression between tumors and normal tissue. We confirmed by RT-qPCR the overexpression of LGALS4, ACS5, SRI, CCT5 and the down-regulation of CLU. By IHC on an independent set of patients, we focused our interest on the genes with the highest differential expression i.e. LGALS4, ACS5 and CLU, and confirmed the results at the protein level for LGALS4 and CLU.
###end p 68
###begin p 69
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The LGALS4 </italic>
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 463 465 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 466 468 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 482 489 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 636 638 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 639 641 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 915 917 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 918 920 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1103 1105 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1106 1108 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1156 1163 1145 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 753 768 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1721 1728 <span type="species:ncbi:9606">patient</span>
The LGALS4 gene codes for the Galectin 4 protein [38]. Galectins constitute a family of proteins containing carbohydrate recognition domains (CRD) with high affinity for beta galactosides. Their complete physiological functions are not known but they have been reported to be involved in inflammation, apoptosis, cell adhesion and cell growth. LGALS4 in particular has been detected in normal epithelial cells of the oral esophagus, and in the intestinal mucosa [39,40]. In tumors, LGALS4 expression increases in liver, gastric, breast cancer and mucinous epithelial ovarian cancer whereas it is down-regulated in colon adenocarcinoma [41-43]. The presence of two binding sites for c-Rel, a subunit of NFkappa-B, and the experimental data obtained with transgenic mice for c-Rel, suggest that LGALS4 could be a downstream component of the NFkappa-B pathway, known to be involved in the regulation of tumorogenesis [44,45]. In cancer cell lines LGALS4 is expressed in highly differentiated cell lines which form polarized monolayers while undifferentiated cell lines do not express LGALS4 but Galectin1 [38,42]. In our series of ethmoid adenocarcinoma, the LGALS4 is the gene with the highest differential expression and our IHC data are in accordance with the literature, given that we found that LGALS4 is overexpressed in all ethmoid tumors except the high-grade non ITAC tumors which are poorly differentiated. LGALS4 expression seems to be correlated to both histological type and the differentiation status of the adenocarcinoma. This trend was confirmed by the P5 case where LGALS4 was overexpressed only in the "colonic-type" component and not in the poorly differentiated "solid-type" component of the tumor. For patient 6 (P6) we observed a strong overexpression of LGALS4 by IHC, which contrasts with the relative expression obtained by RT-qPCR (fold change 0.45). We therefore hypothesize that, in this "mucinous-type" ITAC containing numerous mucin lakes, the RNA extracted from the tissue was not representative of the tumor.
###end p 69
###begin p 70
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU (</italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
The highly conserved gene CLU (apolipoproteinJ, sulfated glycoprotein 2), codes for Clusterin, a sulfated glycoprotein with chaperone activity found in numerous tissues and body fluids. CLU has been reported as being involved in many biological functions such as DNA repair, cell cycle regulation and apoptosis [37,46]. CLU is described as being overexpressed in several types of cancers including colon, breast and lung cancer [37], yet a down-regulation has been found in esophageal squamous cell carcinoma, in some pancreatic, prostate or colon cancers and in HPV-negative squamous cell carcinoma of the head and neck [37,46,47], suggesting a pro-survival or a pro-apoptotic function. The recent description of several isoforms, including the nuclear form (n-CLU) and the cytoplasmic or secreted form (s-CLU), might help to resolve these apparent contradictions and to define the cellular functions of Clusterin as well as its potential use as a biomarker [48-50].
###end p 70
###begin p 71
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1293 1297 1293 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
###xml 374 381 <span type="species:ncbi:9606">patient</span>
###xml 864 872 <span type="species:ncbi:9606">patients</span>
###xml 1033 1041 <span type="species:ncbi:9606">patients</span>
In our series of ethmoid tumors, CLU was highly down-regulated at the RNA level. Although the level of Clusterin detected by IHC in normal tissue was rather low, we confirmed the down-regulation of the protein except in one case (P11). This patient was also the one whose tumor sample showed the least down-regulation of CLU by RT-qPCR. This case is of interest because the patient was exposed to wood and, in contrast with most of the cases reported in the literature, he presented a non-ITAC tumor. The absence of Clusterin in ethmoid tumors suggests a pro-apoptotic function in normal ethmoidal tissue, possibly in response to DNA damage caused by wood dust, or other occupational exposures. It is useful to note that CLU is localized on chromosome 8p21-p12 [51]. In fact, by comparative genomic hybridization, Ariza et al. found losses on 8p21 in about 50% of patients with sinonasal adenocarcinomas [20]. This feature was confirmed by the study of Korinth et al. who reported a loss of 8p in 61% of cases [21] in a series of 42 patients. We do not know the cytogenetics of our tumors but it would be worthwhile ascertaining whether the down-regulation of CLU in the tumors studied here is due to deletion on chromosome 8p or if other mechanisms such as epigenetic regulation occur on the CLU gene.
###end p 71
###begin p 72
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACS5</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FACL5</italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 531 537 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
ACS5, Acyl coenzyme A synthetase 5 (FACL5, E.C. 6.2.1.3.), is one isoform of the ACSs, key proteins in lipid metabolism via the activation of fatty acids in acylCoA thioesters. These esters are the metabolites for oxidation, elongation and desaturation of fatty acids as well as for the synthesis of complex lipids. ACS5 is essential for lipid metabolism but it might also play a role in intermediate metabolism and regulation of gene expression [52]. This gene has been well characterized in the small intestine mucosa by Gassler et al [53,54]. ACS5 is expressed in the enterocytes from the villus tip but not in the crypts and it could be involved in the differentiation and maintenance of crypt-villus axis, by inducing TRAIL apoptosis in apical villi of the mucosa. Within the context of tumorogenesis, few reports have been published on ACS5. In adenoma and adenocarcinoma of the small intestine ACS5 expression is decreased [54] while it is up-regulated in gliomas [55], in well-differentiated endometrioid adenocarcinomas [56] and in certain colorectal adenocarcinomas [57]. The RT-qPCR data in our panel of tumors revealed an increase in the expression of ACS5 (p = 0.001), eventhough it has not been confirmed by IHC. Whereas some tumors expressed strong ACS5, others had completely lost the expression of this molecule. Moreover, we could not find any correlation between ACS5 expression and histological type, differentiation or collateral exposures.
###end p 72
###begin p 73
The other selected genes were not evaluated by immunohistochemistry as their variation in expression was much lower and our primary goal was to find new markers for a better characterization of these tumors with a clear etiology. Nevertheless, we confirmed the transcriptional profiling obtained with the microarray by RT-qPCR.
###end p 73
###begin p 74
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRI </italic>
###xml 5 13 5 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sorcin) </italic>
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5 (</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRI </italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 458 465 <span type="species:ncbi:4097">tobacco</span>
SRI (Sorcin) and CCT5 (chaperonin-containing complexe peptide 1) are less known genes. Both code for multi-drug resistance proteins and might be involved in the cell detoxification [58,59]. These genes were slightly overexpressed in our panel of tumors. This trend could be related to the chemical or particle exposures of the patients. In fact, SRI has also been identified by Differential Display analysis as being overexpressed in oral cancer mediated by tobacco-chewing [60].
###end p 74
###begin title 75
Conclusion
###end title 75
###begin p 76
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS4 </italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU </italic>
###xml 322 330 <span type="species:ncbi:9606">patients</span>
In conclusion, our transcriptomic study has enabled us to identify genes involved in sinonasal adenocarcinomas. The validation of microarray data by RT-qPCR and immunohistochemistry confirmed the significant alterations of LGALS4 and CLU expression. Because of the low incidence of these tumors we had a limited number of patients and only one without wood exposure, preventing any correlation between survival and wood exposure. Nevertheless, after validation using tissue microarrays in a large set of tumors, including pre-cancerous lesions and early stages, LGALS4 and CLU could be included in a panel of non invasive diagnostic/prognostic tests for the follow-up of woodworkers, to allow an earlier detection of lesions using a sinonasal smear.
###end p 76
###begin title 77
Competing interests
###end title 77
###begin p 78
The authors declare that they have no competing interests.
###end p 78
###begin title 79
Authors' contributions
###end title 79
###begin p 80
###xml 88 96 <span type="species:ncbi:9606">patients</span>
TD conceived the design of the study, performed the questionnaire, the follow up of the patients and participated in the drafting of the paper. SQ participated in the tissue collection, performed the molecular and data analyses, and contributed to the drafting of the paper. KR performed the pathological diagnoses and the immunohistochemistry interpretation. CF, OM and CV participated in the tissue collection, IGM to the microarray study. VSR and CG contributed to the design of the study and the epidemiological questionnaire. CGRR participated in the study design, supervised the project and prepared the manuscript. All authors read and approved the final manuscript.
###end p 80
###begin title 81
Pre-publication history
###end title 81
###begin p 82
The pre-publication history for this paper can be accessed here:
###end p 82
###begin p 83

###end p 83
###begin title 84
Supplementary Material
###end title 84
###begin title 85
Additional file 1
###end title 85
###begin p 86
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Primer sequences</bold>
Primer sequences.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 2
###end title 88
###begin p 89
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genes with significant differential expression in sinonasal adenocarcinomas, identified by two-class comparison</bold>
Genes with significant differential expression in sinonasal adenocarcinomas, identified by two-class comparison.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 3
###end title 91
###begin p 92
###xml 30 43 30 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRI and CCT5 </italic>
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relative expression levels of <italic>SRI and CCT5 </italic>in tumors versus matched normal sinonasal tissue as determined by RT-qPCR</bold>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO</italic>
###xml 285 304 285 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2 microglobulin</italic>
###xml 310 321 307 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin C</italic>
Relative expression levels of SRI and CCT5 in tumors versus matched normal sinonasal tissue as determined by RT-qPCR. Fold change was calculated according to the equation described in the Materials and Methods with normalization against the average of three housekeeping genes, RPLPO, beta2 microglobulin, and ubiquitin C. *tumor tissue versus average of all normal sinonasal tissues (cf. RT-qPCR Results for detail).
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Acknowledgements
###end title 94
###begin p 95
We thank Dr. Jean Leger and Dr. Remi Houlgatte for their help with the microarray analysis, Marie-Therese Le Cabellec for the cryostat sections, and Cecile Deleine for the immunohistochemical staining. We are grateful to C. Beauvillain, F. Jegoux, and C. Roedlich for their critical review and helpful discussions during the preparation of the manuscript.
###end p 95
###begin p 96
Grant support: La Ligue Contre le Cancer, comite Pays de la LOIRE; La Direction de la Recherche Clinique du Centre Hospitalo-Universitaire de Nantes.
###end p 96
###begin article-title 97
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review
###end article-title 97
###begin article-title 98
Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies
###end article-title 98
###begin article-title 99
Occupational risks for adenocarcinoma of the nasal cavity and paranasal sinuses in the German wood industry
###end article-title 99
###begin article-title 100
Wood dust and formaldehyde
###end article-title 100
###begin article-title 101
Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries
###end article-title 101
###begin article-title 102
Cancer risk from occupational exposure to wood dust. A pool analysis of epidemiological studies
###end article-title 102
###begin article-title 103
IARC Monogr Eval Carcinog Risks Hum. Leather industries, boot and shoe manufacture and repair
###end article-title 103
###begin article-title 104
Sino-nasal cancer and exposure to leather dust
###end article-title 104
###begin article-title 105
Work-related cancer in the Nordic countries
###end article-title 105
###begin article-title 106
Nasal and sinonasal cancer. Connection with occupational exposures in Denmark, Finland and Sweden
###end article-title 106
###begin article-title 107
Mortality from solid cancers among workers in formaldehyde industries
###end article-title 107
###begin article-title 108
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
###xml 42 49 <span type="species:ncbi:4097">tobacco</span>
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
###end article-title 108
###begin article-title 109
Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review
###end article-title 109
###begin article-title 110
Clinical and pathological considerations in the evaluation of major head and neck specimens resected for cancer. Part II
###end article-title 110
###begin article-title 111
Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases
###end article-title 111
###begin article-title 112
Subcranial fronto-orbito-nasal approach for ethmoidal cancers surgical techniques and results
###end article-title 112
###begin article-title 113
Prognostic factors in sinonasal tumors involving the anterior skull base
###end article-title 113
###begin article-title 114
K-ras mutations in sinonasal cancers in relation to wood dust exposure
###end article-title 114
###begin article-title 115
###xml 17 22 <span type="species:ncbi:9606">human</span>
COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure
###end article-title 115
###begin article-title 116
Comparative genomic hybridization in primary sinonasal adenocarcinomas
###end article-title 116
###begin article-title 117
Chromosomal imbalances in wood dust-related adenocarcinomas of the inner nose and their associations with pathological parameters
###end article-title 117
###begin article-title 118
Genome-wide analysis of genetic changes in intestinal-type sinonasal adenocarcinoma
###end article-title 118
###begin article-title 119
Genetic damage in wood dust-exposed workers
###end article-title 119
###begin article-title 120
Adenocarcinoma
###end article-title 120
###begin article-title 121
Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses
###end article-title 121
###begin article-title 122
RNA integrity and the effect on the real-time qRT-PCR performance
###end article-title 122
###begin article-title 123
###xml 38 44 <span type="species:ncbi:10090">murine</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice
###end article-title 123
###begin article-title 124
###xml 130 135 <span type="species:ncbi:9606">human</span>
Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells
###end article-title 124
###begin article-title 125
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets
###end article-title 125
###begin article-title 126
###xml 109 112 <span type="species:ncbi:9606">man</span>
Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man
###end article-title 126
###begin article-title 127
A dynamic, web-accessible resource to process raw microarray scan data into consolidated gene expression values: importance of replication
###end article-title 127
###begin article-title 128
Significance analysis of microarrays applied to the ionizing radiation response
###end article-title 128
###begin article-title 129
Cluster analysis and display of genome-wide expression patterns
###end article-title 129
###begin article-title 130
GoMiner: a resource for biological interpretation of genomic and proteomic data
###end article-title 130
###begin article-title 131
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 131
###begin article-title 132
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
###end article-title 132
###begin article-title 133
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer
###end article-title 133
###begin article-title 134
Galectin-4 in normal tissues and cancer
###end article-title 134
###begin article-title 135
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle
###end article-title 135
###begin article-title 136
Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism
###end article-title 136
###begin article-title 137
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
###end article-title 137
###begin article-title 138
Expression of galectins in cancer: a critical review
###end article-title 138
###begin article-title 139
A distinct molecular profile associated with mucinous epithelial ovarian cancer
###end article-title 139
###begin article-title 140
###xml 0 25 <span type="species:ncbi:11757">Mouse mammary tumor virus</span>
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors
###end article-title 140
###begin article-title 141
NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy
###end article-title 141
###begin article-title 142
Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control
###end article-title 142
###begin article-title 143
Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas
###end article-title 143
###begin article-title 144
Advances and challenges in basic and translational research on clusterin
###end article-title 144
###begin article-title 145
High clusterin expression correlates with a poor outcome in stage II colorectal cancers
###end article-title 145
###begin article-title 146
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy
###end article-title 146
###begin article-title 147
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human clusterin (CLI) maps to 8p21 in proximity to the lipoprotein lipase (LPL) gene
###end article-title 147
###begin article-title 148
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
Long-chain acyl-CoA-dependent regulation of gene expression in bacteria, yeast and mammals
###end article-title 148
###begin article-title 149
###xml 81 86 <span type="species:ncbi:9606">human</span>
Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine
###end article-title 149
###begin article-title 150
Impaired expression of acyl-CoA-synthetase 5 in epithelial tumors of the small intestine
###end article-title 150
###begin article-title 151
Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas
###end article-title 151
###begin article-title 152
###xml 39 44 <span type="species:ncbi:9606">human</span>
Expression of acyl-CoA synthetase 5 in human endometrium and in endometrioid adenocarcinomas
###end article-title 152
###begin article-title 153
Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas
###end article-title 153
###begin article-title 154
###xml 116 121 <span type="species:ncbi:9606">human</span>
Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers
###end article-title 154
###begin article-title 155
###xml 66 71 <span type="species:ncbi:9606">human</span>
Sorcin, an important gene associated with multidrug-resistance in human leukemia cells
###end article-title 155
###begin article-title 156
###xml 52 59 <span type="species:ncbi:4097">tobacco</span>
Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction
###end article-title 156
###begin article-title 157
TNM staging of cancers of the head and neck: striving for uniformity among diversity
###end article-title 157

